In summary, although increased radiosensitivity of HPV/p16-positive HNSCC has been partially confirmed experimentally, further studies are still needed to identify molecular actors implicated in radioresponse of HPV/p16-positive HNSCC. The gene discussed is CDKN2A; the disease is head and neck squamous cell carcinoma.